The momentum continues for the Animal Care division which continues to receive new orders. The order amounts to approximately
The order is placed by Pompano Veterinary Oncology (PVO) in
"At PVO it is our goal to be at the vanguard of cancer treatment for companion animals. We want to provide progressive and innovative treatments to improve our patient's quality of life while minimizing stress and adverse effects. TSE provides a key weapon in our arsenal against cancer in companion animals that we have been looking for. It allows us to target tumors effectively while sparing healthy normal tissues of undesired damage. As a veterinary oncologist, I appreciate the compact size, "easy to use" feel and portability of vetIQure. With vetIQure, we can provide additional, effective, and safe treatments in our mobile oncology unit "at home", which is much desired by pet owners." - says Dr
For further information please contact:
Phone: +46 (0)10-218 93 00
E-mail: ir@chemotech.se
This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on
ChemoTech is a Swedish medical technology company based in
https://news.cision.com/chemotech/r/scandinavian-chemotech-s-animal-care-division-receives-an-order-from-a-leading-veterinary-hospital-i,c3894609
https://mb.cision.com/Main/14967/3894609/2498156.pdf
(c) 2023 Cision. All rights reserved., source